Select Language
Free Registration
My Cart

CD39/CD73: the critical targets for adenosinergic pathways

The ATP–adenosine pathway functions as a key modulator of innate and adaptive immunity within the tumour microenvironment.
CD39 and CD73, two of the Ectonucleotidases, are involved in converting ATP into extracellular adenosine. CD39 (ectonucleoside triphosphate diphosphohydrolase-1, ENTPD1) converts ATP and ADP to AMP, and CD73 (ecto-5′-nucleotidase, NT5E) converts AMP to adenosine (ADO). ADO is a key metabolite within the TME that accumulates and inhibits the function of important immune cells, including T cells and NK cells, leading to an environment conducive to tumor growth. Consequently, multiple clinical strategies are being explored to target this pathway for the treatment of cancer.
The enzymatic activities of CD39 and CD73 play strategic roles in calibrating the duration, magnitude, and chemical nature of purinergic signals delivered to immune cells through the conversion of ADP/ATP to AMP and AMP to adenosine, respectively.
ACROBiosystems supplies a series of CD39/CD73 proteins with high enzymatic activity, which can help expedite your anti-CD39 and anti-CD73 mAb drug development. The high purity and bioactivity of these proteins have been verified by HPLC / BLI / SPR and ELISA. Protocols are provided for free.

Product Features

Product List

Cat. No.MoleculeProduct DescriptionOrder Now
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order
Order

Assay Data

High purity verified by MALS

The purity of Human CD73, His Tag (HPLC-verified) (Cat. No. CD3-H52H7) was greater than 90% as determined by SEC-HPLC.

Request Report

High bioactivity
ELISA

Immobilized Human CD39, His Tag (Cat. No. CD9-H52H4) at 1 μg/mL (100 μL/well) can bind Anti-CD39 Antibody, Human IgG1 with a linear range of 0.1-0.8 ng/mL (QC tested).

Request Protocol


BLI

Loaded Anti-CD73 MAb (Human IgG1) on AHC Biosensor, can bind Human CD73, His Tag (HPLC-verified) (Cat. No. CD3-H52H7) with an affinity constant of 0.179 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Request Protocol

SPR

Anti-CD73 antibody (Human IgG1) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human CD73, His Tag (HPLC-verified) (Cat. No. CD3-H52H7) with an affinity constant of 0.164 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Request Protocol

High enzymatic activity
Product Human CD39 / ENTPD1 Protein, His Tag Human CD73 / NT5E Protein, His Tag (HPLC-verified)
Hydrolyzed substrate Adenosine-5'-triphosphate (ATP) Adenosine-5'-monophosphate (AMP)
Enzymatic activity
（pmol/min/μg） 		ACRO product
（Cat. No: CD9-H52H4） 		The product of another vendor ACRO product
（Cat. No: CD3-H52H7） 		The product of another vendor
> 6,000 >5,000 >37,000 >15,000

Note: The enzymatic activity of the same product is measured under the same conditions

  • Background
  • Product Features
  • Product List
  • Assay Data
Share to:

[North America]: +1 800-810-0816 [Switzerland]: +41 800 040 012 [Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA [Switzerland]: Switzerland Innovation Park Basel Area, Novartis Campus, Lichtstrasse 35, 4056 Basel

Email：order@acrobiosystems.com

Copyright © 2025 ACROBiosystems. All Rights Reserved

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland